Sectra’s CT-based Micromotion Analysis (CTMA) simplifies and speeds up the process of validating new orthopedic implants in vivo. CTMA uses CT images taken up to one or two years after implantation to measure the 3D motion of an implant or bone fragment on a sub-millimeter scale. This information provides the surgeon and implant manufacturers with a strong predictor of the long-term survival of the implant.